Paola García de la Torre

Dr. Paola García de la Torre

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Neurobiology of Learning and Memory
Verified
Journal Article
Closed access
CRCarlos J. Rodriguez-Ortiz
Carlos J. Rodriguez-Ortiz
PTPaola García de la Torre
Paola García de la Torre
EBEduardo Benavidez
Eduardo Benavidez
MBMaria Angeles Ballesteros
Maria Angeles Ballesteros
FRFederico Bermúdez Rattoni
Federico Bermúdez Rattoni

1 October 2012 in Neurobiology of Learning and Memory
Verified
Journal Article
Closed access
CRCarlos J. Rodriguez-Ortiz
Carlos J. Rodriguez-Ortiz
IBIsraela Balderas
Israela Balderas
PTPaola García de la Torre
Paola García de la Torre
FRFederico Bermúdez Rattoni
Federico Bermúdez Rattoni

25 August 2009 in Learning & Memory
Verified
Journal Article
Open access
PDF file
PTPaola García de la Torre
Paola García de la Torre
CRCarlos J. Rodriguez-Ortiz
Carlos J. Rodriguez-Ortiz
JAJose L. Arreguin-Martinez
Jose L. Arreguin-Martinez
PCPaulina Cruz-Castañeda
Paulina Cruz-Castañeda
FRFederico Bermúdez Rattoni
Federico Bermúdez Rattoni
Reconsolidation has been described as a process where a consolidated memory returns to a labile state when retrieved. Growing evidence suggests that reconsolidation is, in fact, a destabilization/stabilization process that incorporates updated information to a previously consolidated memory. We used the conditioned taste aversion (CTA) task in order to test this theory. On the first trial, the conditioned stimulus (CS) (saccharin) was associated to the unconditioned stimulus (US) (LiCl injection), and as a result, aversion to saccharin was obtained. The following day, animals were injected with anisomycin in either the insular cortex (IC), central amygdala (CeA), basolateral amygdala (BLA), or simultaneously in IC and CeA or IC and BLA, and a second CTA trial was carried out in which updated information was acquired. Animals were tested 24 h later. When protein synthesis was inhibited in either the IC or CeA, consolidation was affected and previously consolidated memory was unimpaired. However, when both the IC and CeA were simultaneously anisomycin injected, the previously consolidated memory was affected. After repeated association trials, protein synthesis inhibition in the IC and CeA did not have an effect on taste memory. These results suggest that the IC and the CeA are necessary for taste-aversion consolidation, and that both share the previously consolidated memory trace. In addition, our data demonstrated that protein synthesis in either the IC or the CeA suffices to stabilize previously consolidated taste memory when destabilized by incorporation of updated information.

5 June 2018 in Biomarkers in Medicine
Verified
Journal Article
Closed access
AIAzul Islas-Hernandez
Azul Islas-Hernandez
HAHugo Seacatl Aguilar-Talamantes
Hugo Seacatl Aguilar-Talamantes
BBBrenda Bertado-Cortes
Brenda Bertado-Cortes
GMGeorgina de Jesus Mejia-Delcastillo
Georgina de Jesus Mejia-Delcastillo
RCRaul Carrera-Pineda
Raul Carrera-Pineda
PTPaola García de la Torre
Paola García de la Torre
Aim: Determine if serum levels of tau and BDNF can be used as severity biomarkers in multiple sclerosis (MS). Patients & methods: Subjects with MS, older than 18 and younger than 55 years old were included; 74 patients with a diagnosis of relapsing–remitting MS, 11 with secondary-progressive MS, and 88 controls were included. Total tau and BDNF were measured by Western blot. Results: Increased tau and decreased BDNF in MS patients compared with controls was found. Total-tau has a peak in relapsing–remitting MS, the second decile of the multiple sclerosis severity score, and in the lowest expanded disability status scale and is no different than controls for secondary-progressive MS patients and the most severe cases of MS. Conclusion: BDNF is a good biomarker for diagnosis of MS but not for severity or progression. Tau appears to have a more active role in the progression of MS.

8 July 2024 in Archives of Medical Research
Verified
Journal Article
Closed access
SCSelma Karime Castillo-Vazquez
Selma Karime Castillo-Vazquez
LMLourdes Massieu
Lourdes Massieu
RRRuth Rincón-Heredia
Ruth Rincón-Heredia
PTPaola García de la Torre
Paola García de la Torre
RQRicardo Quiroz-Baez
Ricardo Quiroz-Baez
Nadia RiveroNadia Rivero
Nadia Rivero

16 August 2010 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
PTPaola García de la Torre
Paola García de la Torre
RORodríguez‐ Ortiz
Rodríguez‐ Ortiz
CJCarlos J.
Carlos J.
IBIsraela Balderas
Israela Balderas
FRFederico Bermúdez Rattoni
Federico Bermúdez Rattoni